Severe hypoglycemia in youth with T1DM: Going, going ... but not yet gone

Pediatric Diabetes

Volumn 12, Issue 1, 2011, Pages 1-3

  Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN DERIVATIVE; ISOPHANE INSULIN; LONG ACTING INSULIN; PIG INSULIN;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DISEASE SEVERITY; DRUG SAFETY; EDITORIAL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; JUVENILE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN INFUSION SYSTEMS;

EID: 79251497366     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00754.x     Document Type: Editorial

References (12)

1. The DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial. N Engl J Med 1993: 329: 977-986.
2. The DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: the diabetes control and complications trial. J Pediatr 1994: 125: 177-188.
3. Mohn A, Matyka K, Harris D, Ross K, Edge J, Dunger DB. Lispro or regular insulin for multiple injection therapy in adolescents: differences in the insulin and glucose levels overnight. Diabetes Care 1999: 23: 27-32.
4. Chase P, Arslanian S, White NH, Usiskin K, Tamborlane WV for the 4030 Study group. Insulin glargine vs intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes. J Pediatr 2008: 153: 547-553.
5. Heise T, Nosek L, Rønn BB et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004: 53: 1614-1620.
6. Phillip M, Battelino T, Rodriquez H, Danne T, Kaufman F and the Consensus Conference Committee. Consensus statement on the use of insulin pump therapy in the pediatric age group. Diabetes Care 2007: 30: 1653-1662.
7. JDRF CGM Study Group. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow up of the JDRF continuous glucose monitoring randomized trial. Diabetes Tech Therap 2010: 12: 507-515.
8. Bergenstal RM, Tamborlane WV, Ahmann A et al. for the STAR 3 Study Group. Effectiveness of sensor-augmented insulin pump therapy in type 1 diabetes. N Engl J Med 2010: 363: 311-320.
9. Blasetti A, Di Giulio C, Tocco AM et al. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study. Pediatr Diabetes 2011.
10. The Diabetes Research in Children Network (DirecNet) Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes. J Pediatr 2005: 147: 528-534.
11. Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F. Duration of nocturnal hypoglycemia before seizures. Diabetes Care 2008: 31: 2110-2112.
12. Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular insulin and lispro insulin after interruption of CSII and in the treatment of acutely decompensated IDDM. Diabetes Care 1998: 21: 817-821.